Milestone Scientific (MLSS) Return on Capital Employed (2011 - 2026)
Milestone Scientific (MLSS) posted Return on Capital Employed of 150.05% for Q1 2026, down 5.47% sequentially from 142.27% in Q4 2025, and down 422.0% YoY from 46.6% in Q1 2025.
Milestone Scientific (MLSS) Return on Capital Employed (2011 - 2026) Analysis & Trends
Milestone Scientific has reported Return on Capital Employed for 16 years, with the latest figure at 150.05% in Q1 2026.
- Quarterly Return on Capital Employed fell 422.0% year-over-year to 150.05% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 150.05% (down 422.0% YoY) and the FY2025 annual result came in at 121.97%, down 2319.0% from the prior year.
- Return on Capital Employed slipped to 150.05% in Q1 2026 per MLSS's latest filing, from 142.27% in the prior quarter.
- Over five years, Return on Capital Employed peaked at 53.22% in Q1 2022 and troughed at 206.33% in Q3 2025.
- A 5-year average of 104.23% and a median of 87.78% in 2023 frame the typical range for Return on Capital Employed.
- The sharpest annual moves came in 2024 and 2025: Return on Capital Employed jumped 241 bps in 2024, then slumped 12050 bps in 2025.
- Over 5 years, Return on Capital Employed stood at 78.88% in 2022, then declined by 9 bps to 85.6% in 2023, then decreased by 18 bps to 100.74% in 2024, then plunged by 41 bps to 142.27% in 2025, then retreated by 5 bps to 150.05% in 2026.
- According to Business Quant data, Return on Capital Employed over the past three periods registered 150.05%, 142.27%, and 206.33% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 132.71 Bn | 127.50 Bn | 1.96 Bn | 18.58% |
| 2 | Becton Dickinson | 51.57 Bn | 50.71 Bn | 2.32 Bn | 6.00% |
| 3 | Alcon | 35.52 Bn | 34.17 Bn | 1.68 Bn | 28.11% |
| 4 | Resmed | 33.28 Bn | 31.81 Bn | 861.22 Mn | 25.22% |
| 5 | Medline | 27.86 Bn | 25.18 Bn | 2.22 Bn | 5.57% |
| 6 | West Pharmaceutical Services | 25.15 Bn | 24.71 Bn | 329.20 Mn | 19.71% |
| 7 | Solventum | 15.31 Bn | 14.91 Bn | 1.29 Bn | 19.76% |
| 8 | Cooper Companies | 14.86 Bn | 14.72 Bn | 735.40 Mn | 4.68% |
| 9 | Baxter International | 13.63 Bn | 11.48 Bn | 1.03 Bn | 3.28% |
| 10 | Milestone Scientific | 39.41 Mn | 36.80 Mn | 1.56 Mn | -150.16% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -150.05% |
| Dec 31, 2025 | -142.27% |
| Sep 30, 2025 | -206.33% |
| Jun 30, 2025 | -145.97% |
| Mar 31, 2025 | -145.83% |
| Dec 31, 2024 | -100.74% |
| Sep 30, 2024 | -85.83% |
| Jun 30, 2024 | -86.10% |
| Mar 31, 2024 | -93.95% |
| Dec 31, 2023 | -85.60% |
| Sep 30, 2023 | -88.25% |
| Jun 30, 2023 | -87.78% |
| Mar 31, 2023 | -79.88% |
| Dec 31, 2022 | -78.88% |
| Sep 30, 2022 | -77.24% |
| Jun 30, 2022 | -64.03% |
| Mar 31, 2022 | -53.22% |
| Dec 31, 2021 | -43.80% |
| Sep 30, 2021 | -41.27% |
| Jun 30, 2021 | -34.54% |